Advancing Medicine Through Evidence-Based Innovation
MD Stem Cells is a premier clinical research organization dedicated to the advancement of regenerative medicine. We provide patients worldwide with access to investigational stem cell treatments through physician-directed, NIH-registered clinical studies.
By combining cutting-edge cellular science with rigorous medical oversight, we offer a specialized pathway for those seeking new options for vision loss and neurodegenerative conditions.
Our Mission: Providing "Informed Hope"
Our mission is built on the philosophy of Informed Hope. We believe patients facing life-altering diagnoses deserve access to the latest scientific advancements, provided those options are grounded in transparency and ethical research. We aim to provide evidence-based opportunities for patients where traditional standard-of-care treatments may be limited, always prioritizing clinical integrity over over-promising results.
Global Expertise in Cellular Therapy
With over a decade of dedicated experience, MD Stem Cells is recognized as the world's most experienced provider of cellular therapies for ophthalmologic and neurologic diseases. Our expertise is focused on:
Autologous Bone-Marrow-Derived Stem Cells (BMSCs)
We utilize the patient's own stem cells, a gold-standard approach that maximizes safety and biological compatibility.
Specialized Protocols
Our team has pioneered specific delivery methods designed to target the unique needs of the eye and the central nervous system.
Validated Research
Our work is conducted through two primary NIH-registered studies:
SCOTS 2:
The Stem Cell Ophthalmology Treatment Study.-
NEST:
The Neurologic Stem Cell Treatment Study.
Dr. Steven Levy | Study Director
The clinical direction of MD Stem Cells is led by Dr. Steven Levy, a prominent figure in regenerative medicine research. Dr. Levy oversees the design and implementation of our study protocols, ensuring every procedure adheres to strict safety and regulatory standards.
Under his leadership, our team of board-certified specialists, including expert hematologists, ophthalmologists, and neurologists-works in concert to provide a high level of surgical and diagnostic excellence. Our collective focus remains on scientific documentation and the wellbeing of every study participant.
Commitment to Scientific Credibility
We believe that transparency is the foundation of patient trust. The clinical work of MD Stem Cells is not just anecdotal; it is part of a growing body of medical literature.
Peer-Reviewed Research
Data from our studies have been featured in numerous medical journals.
Independent Documentation
Outcomes within our study frameworks are documented by independent, third-party specialists to ensure objective reporting.
Regulatory Compliance
All procedures utilize FDA-compliant cell processing and are conducted within NIH-registered clinical study frameworks.
A Structured, Patient-Centered Approach
Enrollment in a regenerative medicine clinical study at MD Stem Cells follows a precise, professional journey designed for safety and clarity:
Rigorous Evaluation
A deep-dive medical review to determine if a patient meets our strict eligibility criteria.
Autologous Procedure
A minimally invasive bone marrow aspiration followed by targeted delivery of concentrated stem cells.
Comprehensive Follow-Up:
Continuous communication and data collection to monitor progress and contribute to global medical knowledge.
Our Promise: Transparency and Safety
We understand the weight of the decisions our patients face. We are committed to compassionate communication, providing you with a clear understanding of the investigational nature of our treatments. While we are proud of the progress made within our studies, we maintain that individual results vary and treatments are not considered an FDA-approved treatment.
Explore Your Eligibility
Discover if our clinical studies are the right fit for your medical journey. Our team is here to guide you through the science, the process, and the possibilities.
Our Research Contributions
Patients seeking advanced treatment options for complex neurologic and ophthalmologic conditions discover hope through our scientifically rigorous approach.